YI-850 DOSE-DEPENDENT IMPROVEMENT IN HIGH-DENSITY LIPOPROTEIN METABOLISM WITH ROSUVASTATIN IN THE METABOLIC SYNDROME

2007 ◽  
Vol 8 (1) ◽  
pp. 225
Author(s):  
E.M.M. Ooi ◽  
G.F. Watts ◽  
P.J. Nestel ◽  
D. Sviridov ◽  
A. Hoang ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
High Density Lipoprotein ◽  
Lipoprotein Metabolism ◽  
Density Lipoprotein ◽  
High Density ◽  
The Metabolic Syndrome ◽  
Dose Dependent

Th-P15:185 High-density lipoprotein transport in the metabolic syndrome: Application of a new model for HDL particle kinetics

2006 ◽  
Vol 7 (3) ◽  
pp. 534
Author(s):  
J. Ji ◽  
G.F. Watts ◽  
A.G. Johnson ◽  
D.C. Chan ◽  
E.M.M. Ooi ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
High Density Lipoprotein ◽  
Density Lipoprotein ◽  
High Density ◽  
New Model ◽  
The Metabolic Syndrome

scholarly journals Effect of the components of the metabolic syndrome on pulmonary function. The unexpected role of high-density lipoprotein cholesterol

2019 ◽  
Vol 86 (2) ◽  
Author(s):  
Saúl Huerta-Ramírez ◽  
Angélica Paniagua-Pérez ◽  
David Castro-Serna ◽  
Andrés Ledesma-Velázquez ◽  
Alberto Rubio-Guerra ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Pulmonary Function ◽  
High Density Lipoprotein ◽  
High Density Lipoprotein Cholesterol ◽  
Density Lipoprotein ◽  
High Density ◽  
Lipoprotein Cholesterol ◽  
The Metabolic Syndrome

scholarly journals Is the Decreased High-Density Lipoprotein Cholesterol in the Metabolic Syndrome Due to Cellular Lipid Efflux Defect?

2004 ◽  
Vol 89 (2) ◽  
pp. 761-764 ◽  
Author(s):  
Mohammad Y. Alenezi ◽  
Michel Marcil ◽  
David Blank ◽  
Mark Sherman ◽  
Jacques Genest
Keyword(s):  
Metabolic Syndrome ◽  
High Density Lipoprotein ◽  
High Density Lipoprotein Cholesterol ◽  
Density Lipoprotein ◽  
High Density ◽  
Lipoprotein Cholesterol ◽  
Cellular Lipid ◽  
The Metabolic Syndrome ◽  
Lipid Efflux

HIGH-DENSITY LIPOPROTEIN SUBCLASSES IN PATIENTS WITH OR WITHOUT THE METABOLIC SYNDROME

2008 ◽  
Vol 9 (1) ◽  
pp. 126-127
Author(s):  
K.G. Lagos ◽  
I.F. Gazi ◽  
M.S. Kostapanos ◽  
T. Filippatos ◽  
P.S. Kazakou ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
High Density Lipoprotein ◽  
Density Lipoprotein ◽  
High Density ◽  
Lipoprotein Subclasses ◽  
The Metabolic Syndrome

scholarly journals Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol

2008 ◽  
Vol 17 (11) ◽  
pp. 1695-1704 ◽  
Author(s):  
Latisha Love-Gregory ◽  
Richard Sherva ◽  
Lingwei Sun ◽  
Jon Wasson ◽  
Timothy Schappe ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
High Density Lipoprotein ◽  
High Density Lipoprotein Cholesterol ◽  
Density Lipoprotein ◽  
High Density ◽  
Lipoprotein Cholesterol ◽  
The Metabolic Syndrome ◽  
Cd36 Gene

scholarly journals Adiponectin in Childhood and Adolescent Obesity and Its Association with Inflammatory Markers and Components of the Metabolic Syndrome

2006 ◽  
Vol 91 (11) ◽  
pp. 4415-4423 ◽  
Author(s):  
Jeffrey C. Winer ◽  
Tosca L. Zern ◽  
Sara E. Taksali ◽  
James Dziura ◽  
Anna M. G. Cali ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Metabolic Syndrome ◽  
Childhood Obesity ◽  
High Density Lipoprotein ◽  
Children And Adolescents ◽  
Density Lipoprotein ◽  
High Density ◽  
Low Grade ◽  
Obese Children ◽  
The Metabolic Syndrome

Abstract Context: Adiponectin levels are lower in obese children and adolescents, whereas markers of inflammation and proinflammatory cytokines are higher. Hypoadiponectinemia may contribute to the low-grade systemic chronic inflammatory state associated with childhood obesity. Objective: We investigated whether C-reactive protein (CRP), the prototype of inflammation, is related to adiponectin levels independently of insulin resistance and adiposity. Design, Setting, Participants, and Main Outcome Measures: In a multiethnic cohort of 589 obese children and adolescents, we administered a standard oral glucose tolerance test and obtained baseline measurements for adiponectin, plasma lipid profile, CRP, IL-6, and leptin. Results: Stratifying the cohort into quartiles of adiponectin levels and adjusting for potential confounding variables, such as age, gender, ethnicity, body mass index z-score, pubertal status, and insulin sensitivity, the present study revealed that low levels of adiponectin are associated not only with higher CRP levels, but also with components of the metabolic syndrome, such as low high-density lipoprotein cholesterol and a high triglyceride-to-high-density-lipoprotein ratio. Conclusions: The link between adiponectin levels and a strong marker of inflammation, CRP, is independent of insulin resistance and adiposity in obese children and adolescents. Adiponectin may be one of the signals linking inflammation and obesity. Thus, adiponectin may function as a biomarker of the metabolic syndrome in childhood obesity.

Sign in / Sign up

Export Citation Format

Share Document